Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 2/20 | 0.41 |
| ▸ | EGLN2 | Q96KS0 | 2/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | TTR | P02766 | 1/20 | 0.35 |
| ▸ | ALB | P02768 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 3/20 | 0.33 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4694668 | 0.90 | GRM5 (0.46) | GRM5EGLN2TTRALBAPP | |
| SCHEMBL20698865 | 0.86 | GRM5 (0.46) | GRM5EGLN2TTRALBAPP | |
| SCHEMBL25857951 | 0.85 | GRM5 (0.41) | GRM5EGLN2TTRALBAPP | |
| SCHEMBL4693793 | 0.84 | GRM5 (0.42) | GRM5EGLN2ACHETTRALB | |
| SCHEMBL14949281 | 0.84 | ACHE (0.48) | ACHEAPPKDM4EMAPTALDH1A1 | |
| SCHEMBL2160632 | 0.80 | GRM5 (0.42) | GRM5EGLN2ACHETTRALB | |
| SCHEMBL16952693 | 0.79 | CYP2A6 (0.48) | GRM5EGLN2ACHETTRALB | |
| SCHEMBL23734489 | 0.78 | ACHE (0.61) | ACHEAPPMAPTALDH1A1 | |
| SCHEMBL14949268 | 0.78 | ACHE (0.42) | ACHEMAPTALDH1A1 | |
| SCHEMBL9948037 | 0.78 | GRM5 (0.41) | GRM5EGLN2TTRALBAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1463501-B1 | CIS-IMIDAZOLINES AS MDM2 INHIBITORS | HOFFMANN LA ROCHE (CH) | 2008-06-11 | — | — | EP | disclosed |
| EP-1463501-A1 | CIS-IMIDAZOLINES AS MDM2 INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2004-10-06 | — | — | EP | disclosed |
| US-6617346-B1 | Inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity | HOFFMANN-LA ROCHE INC. | 2003-09-09 | — | — | US | disclosed |
| WO-2003051360-A1 | CIS-IMIDAZOLINES AS MDM2 INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2003-06-26 | — | — | WO | disclosed |